Cipla Limited has informed the Exchange regarding a press release dated October 20, 2020, titled "Cipla launches Nintib (Nintedanib capsules 100 mg, 150 mg) to treat Idiopathic Pulmonary Fibrosis, in continuation of its fight against rare lung diseases".